OralDosed ingredient Cosmetic cross-reference

Calcium Carbonate

CAS 471-34-1

Calcium Carbonate (CAS 471-34-1) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 16,011 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
16,011
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Calcium Carbonate
CAS Number
471-34-1
UNII
H0G9379FGK
InChIKey
VTYYLEPIZMXCLO-UHFFFAOYSA-L
ChEMBL ID
CHEMBL1200539
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
HYDROLYZED PEARLCALCITECI 77220CHALK
dosed ingredientoral
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200539 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Myocardial infarction 8553 2323.864 10028596
Completed suicide 824 1925.812 10010144
Coronary artery disease 3988 1760.963 10011078
Toxicity to various agents 3260 1727.839 10070863
Drug abuse 366 1725.422 10013654
Acute myocardial infarction 3619 1196.974 10000891
Cardiac failure congestive 5738 1131.129 10007559
Off label use 14394 1108.742 10053762
Cerebrovascular accident 5961 933.302 10008190
Febrile neutropenia 1978 900.319 10016288
Drug ineffective 19971 842.64 10013709
Gastrointestinal haemorrhage 5322 830.51 10017955
Product use in unapproved indication 3076 654.305 10076476
Death 9754 601.426 10011906
Angina unstable 1034 512.666 10002388
Angina pectoris 2226 509.687 10002383
Intentional overdose 787 505.783 10022523
Disease progression 2376 466.097 10061818
Pemphigus 5427 450.784 10034280
Coronary arterial stent insertion 567 447.154 10052086
Malignant neoplasm progression 1437 436.471 10051398
Suicide attempt 644 427.591 10042464
Coronary artery bypass 557 417.716 10011077
Systemic lupus erythematosus 5903 411.317 10042945
Overdose 2184 387.609 10033295
Thrombosis in device 519 378.028 10062546
Device expulsion 57 370.799 10012578
Glossodynia 5097 360.357 10018388
Transient ischaemic attack 2065 348.077 10044390
Milk-alkali syndrome 253 347.723 10027635
Haemoglobin decreased 6283 341.179 10018884
Coronary artery occlusion 882 339.618 10011086
Neutropenia 4094 339.521 10029354
No adverse event 525 315.275 10067482
Gastric haemorrhage 796 310.561 10017788
Drug dependence 222 308.734 10013663
Drug reaction with eosinophilia and systemic symptoms 419 301.398 10073508
Haemorrhage 3244 300.604 10055798
Drug resistance 307 296.08 10059866
Labelled drug-drug interaction medication error 1116 291.276 10064373
Vascular stent thrombosis 370 288.71 10063934
Abdominal discomfort 8816 283.332 10000059
Intentional product misuse 902 273.349 10074903
Chest pain 7543 271.081 10008479
Intentional self-injury 164 266.867 10022524
Coronary artery stenosis 675 264.11 10011089
Hand deformity 4405 263.958 10061194
Myocardial ischaemia 1105 261.291 10028600
Cytomegalovirus infection 305 255.758 10011831
Aspirin-exacerbated respiratory disease 204 253.426 10075084

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 9 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
HYDROLYZED PEARL 1897 SU MTHSPL
CALCITE 1897 SU MTHSPL
CI 77220 1897 SU MTHSPL
CALCIUM CARBONATE 1897 SU MTHSPL
Calcium Carbonate 1897 SU MTHSPL
Calcium carbonate 1897 SU MTHSPL
calcium carbonate 1897 SU MTHSPL
CHALK 66862 SU MTHSPL
calcium carbonate 1897 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Calcium Carbonate used for in pharmaceutical contexts?

Calcium Carbonate (CAS 471-34-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Calcium Carbonate?

Calcium Carbonate has 16,011 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Myocardial infarction, Completed suicide, Coronary artery disease, Toxicity to various agents, Drug abuse. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Calcium Carbonate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Carbonate — Structured Cosmetic Ingre with EU status "permitted".

What clinical phase is Calcium Carbonate in?

Calcium Carbonate is rendered with ChEMBL max phase 4 (approved).